Novel rivaroxaban—loaded poly (lactic-co-glycolic acid)/poloxamer nanoparticles: Preparation, physicochemical characterization, in vitro evaluation of time …

ME Machado, P de Souza Furtado, CCB Araújo… - …, 2021 - iopscience.iop.org
Rivaroxaban (RXB), an oral direct factor Xa inhibitor, presents innovative therapeutic profile.
However, RXB has shown adverse effects, mainly due to pharmacokinetic limitations …
被引用次数：15 相关文章

Novel rivaroxaban—loaded poly (lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time …

ME Machado, P de Souza Furtado… - …, 2021 - ui.adsabs.harvard.edu
Rivaroxaban (RXB), an oral direct factor Xa inhibitor, presents innovative therapeutic profile.
However, RXB has shown adverse effects, mainly due to pharmacokinetic limitations …

Novel rivaroxaban-loaded poly (lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent …

ME Machado, P de Souza Furtado… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Rivaroxaban (RXB), an oral direct factor Xa inhibitor, presents innovative therapeutic profile.
However, RXB has shown adverse effects, mainly due to pharmacokinetic limitations …

Novel rivaroxaban-loaded poly (lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent …

ME Machado, P de Souza Furtado… - …, 2021 - europepmc.org
Rivaroxaban (RXB), an oral direct factor Xa inhibitor, presents innovative therapeutic profile.
However, RXB has shown adverse effects, mainly due to pharmacokinetic limitations …

Novel rivaroxaban—loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time …

ME Machado, P De Souza Furtado… - Nanotechnology …, 2021 - inis.iaea.org
[en] Rivaroxaban (RXB), an oral direct factor Xa inhibitor, presents innovative therapeutic
profile. However, RXB has shown adverse effects, mainly due to pharmacokinetic limitations …